J.ESTINA Co.,Ltd. (KOSDAQ:026040)
2,900.00
-50.00 (-1.69%)
At close: Apr 30, 2026
J.ESTINA Revenue
J.ESTINA had revenue of 18.98B KRW in the quarter ending September 30, 2022, with 16.68% growth. This brings the company's revenue in the last twelve months to 76.92B, up 20.29% year-over-year. In the year 2021, J.ESTINA had annual revenue of 67.33B with 12.22% growth.
Revenue (ttm)
76.92B
Revenue Growth
+20.29%
P/S Ratio
0.54
Revenue / Employee
244.19M
Employees
315
Market Cap
41.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 67.33B | 7.33B | 12.22% |
| Dec 31, 2020 | 60.00B | -34.99B | -36.83% |
| Dec 31, 2019 | 94.99B | -32.36B | -25.41% |
| Dec 31, 2018 | 127.35B | -12.60B | -9.00% |
| Dec 31, 2017 | 139.95B | -30.30B | -17.80% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Asia Technology Co.,Ltd | 96.24B |
| GeneBioTech Co. ,Ltd | 90.79B |
| BCWORLD PHARM. | 75.80B |
| MegaMD | 35.19B |
| Abpro Bio | 31.92B |
| INNOAX CO.,LTD | 22.93B |
| Mason Capital | 20.69B |
| S-CHEM | 17.90B |